Apogee Therapeutics, Inc. (APGE) — Stock Score Summary

Apogee Therapeutics, Inc. (APGE) has a MoatMap StockRank of 58/100 based on Quality (43/100), Value (37/100), and Momentum (62/100) factor scores. The current signal is HOLD. Apogee Therapeutics is an early-stage biotech company with no current revenues, violating our Terry Smith and Warren Buffett lenses requiring proven cash flows and moats.

Apogee Therapeutics, Inc. is a biotechnology company focused on developing novel antibody therapeutics for inflammatory and immunological diseases, with a pipeline targeting conditions like atopic dermatitis and COPD. The company aims to differentiate its antibody candidates through enhanced potency, half-life, and novel mechanisms of action to improve upon existing treatments. Apogee is a clinical-stage biotech firm strategically developing next-generation biologics for chronic inflammatory diseases, leveraging advanced antibody engineering.

Key Financial Metrics

Price$84.37
Market Cap$5.9B
P/E (Forward)-17.74
Price/Book5.39
Return on Equity-28.5%
Return on Invested Capital-31.4%
Debt/Equity0.64
Gross Margin0.0%
Operating Margin0.0%
Free Cash Flow$-143M

Apogee Therapeutics, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Apogee Therapeutics, Inc.’s (APGE) StockRank?
MoatMap’s StockRank for Apogee Therapeutics, Inc. (APGE) is 58/100, with a Hold signal. It is a composite of Quality (43), Value (37), and Momentum (62) factor ranks across MoatMap’s 19,000+ stock universe.
Does Apogee Therapeutics, Inc. have an economic moat?
Apogee Therapeutics, Inc. (APGE) has a Quality factor score of 43/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Apogee Therapeutics, Inc. a buy, hold, or sell?
MoatMap’s current signal for Apogee Therapeutics, Inc. (APGE) is Hold, based on a StockRank of 58/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Apogee Therapeutics, Inc. in?
Apogee Therapeutics, Inc. (APGE) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksAPGE deep dive reportAI ChampionsHow we score stocksSense-check another stock